Assertio Holdings | DEPO - Selling And Administration Expenses

Stock Price
19.39
Daily Change
-0.14 -0.72%
Monthly
64.74%
Yearly
86.88%
Q1 Forecast
18.01

Assertio Holdings reported $16.73M in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.





Selling And Administration Expenses Change Date
ANI Pharmaceuticals USD 82.79M 6.13M Dec/2025
Assertio Holdings USD 16.73M 1.66M Sep/2024
Aurora Cannabis CAD 40.62M 1.17M Dec/2025
Cara Therapeutics USD 4.64M 2.19M Mar/2025
Daiichi Sankyo JPY 228.23B 39.15B Dec/2025
Ironwood Pharmaceuticals USD 33.33M 2.78M Dec/2024
J&J USD 6.75B 831M Dec/2025
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Merck USD 2.85B 215M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Omeros USD 11.32M 2.48M Sep/2024
Pfizer USD 4.08B 894M Dec/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025